Dr. Balvir Singh Tomar Cancer and Research Institute

Our aim is to promote India’s development and self-reliance through affordable cancer treatment – Dr. Tomar

Positioned to take a monumental leap towards transformative cancer care, Dr. Balvir Singh Tomar Cancer and Research Institute, a pivotal arm of the esteemed Nims Hospital and Nims University, announces the inauguration of a state-of-the-art cancer treatment facility. This landmark initiative signifies a new chapter in Rajasthan’s healthcare essay and represents a light of hope for countless cancer patients seeking affordable and compassionate care. Partnerships with RGHS Chiranjeevi and various TPA services are additional assurances for smooth passage into high-quality healthcare, aligning with the mission to envision a healthier, cancer-free future for the residents of Rajasthan and India.

At the heart of this development lies the introduction of the Verian Tubim HD-MLC Linear Accelerator, a fully robotic LINAC considered the epitome of cancer radiation technology. Its services encompass 3D-CRT (3D Conformal Radiation Therapy), IMRT (Intensity Modulated Radiotherapy), TBI (Total Body Irradiation), Gating Radiotherapy, SRS (Stereotactic Radio Surgery), SBT (Stereotactic Body Radiation Therapy), and SRT (Stereotactic Radiotherapy). This advanced system enables high-dose treatments with sub-millimeter precision, offering Stereotactic Body Radiation Therapy (SBRT), in record time. This robust suite of radio-therapeutic techniques emphasizes occupation of the latest advancements, providing patients with a diverse range of treatment options modified to their unique needs.

The Institute further divulges Rajasthan’s first deep learning MRI machine, the 3-Tesla MRI (VIDA-XT). Implementing the Siemens Biometrics Beat Sensor technology, this machine guarantees superior imaging quality for the entire human anatomy while delivering results in less than 1/5th of the time required by traditional MRIs.

As it utilizes the Lutetium Oxyorthosilicate (LSO) technology, the PET-CT Siemens Biograph emerges as a game-changer in cancer diagnostics. With supreme precision, it diagnoses smaller lesions and reduces the required doses of Fluoro-deoxyglucose (FDG), prioritizing patient safety while ensuring diagnostic excellence.

Yet another first for Rajasthan, the Institute additionally presents the 384-slice Dual Source Energy CT Machine, harboring the technology to create clearer images with the lowest radiation dose and enhancing diagnostic accuracy that underscores the Institute’s pledge to patient welfare. Bringing a paradigm shift in medical diagnostics in Rajasthan, this cancer institute proudly presents the state’s premier 384-slice dual-source energy CT machine. Adopting advanced technology, this state-of-the-art CT machine has been designed in the field of oncology. High-resolution capabilities play a vital role in early detection of tumors, ensuring clarity in imaging, which, in turn, facilitates cancer staging.

The detailed images generated by this CT machine help contribute to better patient outcomes, which is essential in the care of individuals facing cancer.

The Centre employs the latest in 3D Mammography technology, aiding in the accurate diagnosis of breast cancer, particularly in dense breast tissue. 3D mammography technology, also known as digital breast tomosynthesis, plays an important role in the day-to-day detection and diagnosis of breast cancer in women. Unlike 2D mammography, 3D mammography captures multiple images of the breast from different angles and detects cancer. This 3D mammography machine is also capable of detecting small tumors too. The use of 3D mammography technology is an example of a proactive approach to breast cancer screening, providing women with more reliable and convenient access to breast health assessment. This technological advancement facilitates early detection and precise treatment planning, contributing to improved patient outcomes.

Leaving behind conventional approaches, the Centre has seamlessly integrated Brachytherapy with LINAC, offering unparalleled versatility in treating all kinds of high-dose (Ir-192) cancer cases. This fully integrated system exemplifies comprehensive cancer care and marks its position as a leader in the field.

Going above and beyond traditional chemotherapy, it offers an all-inclusive range of services adapted to meet the diverse needs of cancer patients. The Institute breaks new record as it presents innovative therapies such as immunotherapy, targeted therapy, hormonal therapy, and TACE (Trans Arterial Kybo Embolization). From advanced radiotherapy, chemotherapy, and cancer surgery to progressive imaging and image-guided interventional oncology, it ensures a panoramic and personalized approach to cancer treatment.

The Institute boasts a state-of-the-art Cancer Surgery Operation Theater, ensuring optimal conditions for intricate surgical procedures. Implementing the practice of onco-plastic surgery combines the principles of oncology with plastic surgery techniques, aiming for both effective cancer removal and aesthetically pleasing results. Moreover, the incorporation of surgical robots accentuates precision and innovation in cancer surgery

Prof. (Dr.) Balvir S. Tomar, Chairman and Chancellor stated that, “It symbolizes a moment in time, a formidable challenge that demands increased awareness and emotional well-being.” The new Cancer Hub brings together cancer care and research in one place, giving patients access to more innovative clinical trials developed on-site and unprecedented will have access to treatments. Physicians will also be able to collaborate in real time, allowing them to be more with our nationally recognized experts and world-class care teams; we are ready to provide even better care.

He continued, “Cancer hospital stands not just a building of bricks and mortar, but my untiring perseverance to carve a sanctuary of healing and hope in the face of the adversity posed by cancer.”

At its deep roots, the Institute has a profoundly ingrained patient-centric philosophy. A team of experienced and concerned doctors and nurses collaborate to provide advanced medical care and stanch emotional support throughout the entire treatment journey. The distinguished staff possesses unparalleled expertise in the nations globally, renowned for their experience in radiation oncology, surgical oncology, medical oncology, interventional oncology, and on-pathology.

This wealth of knowledge is complemented by the esteemed professionals, including Dr. Rohistasv Dana, Dr. Simanta Kumar Behra, Dr. Aditya Kumar, Dr. Rajashekhar Mahalingam from the Department of Radiation Oncology, Dr. Naveen Sharma, Dr. Anuj Singh, and Dr. Jayveer Singh Shekhawat from the branch of Surgical Oncology, Dr. Gul Mohd. Bhatt, Dr. Sandeep Kumar Bairva, and Dr. Anu Rajpurohit are from Medical Oncology Department, and lastl Prof. (Dr.) Sanjeev Sharma, Dr. Sandeep Mudgil, Dr. Manish Shaw, Dr. Praveen Singhal, and Dr. Madan Mohan Gupta from the department of Interventional Oncology along with Dr. Pranav Dey representing Onco-Pathology.

Together, this team of experts contributes to building merit in various facets of oncology, ensuring a world-class approach for the patients. With the launch of these revolutionary services, Dr. Balvir Singh Tomar Cancer and Research Institute solidify its loyalty to approaching the boundaries of cancer care that is advanced and benevolent. The Institute aims to contribute significantly to the fight against cancer by blending technology with compassionate patient care. It stands as a source of optimism for cancer patients in Rajasthan, presenting an innovative strategy in cancer care that integrates cost-effectiveness with top-notch clinical amenities. This endeavor represents a major achievement in the state’s healthcare scenario, introducing one of the globe’s most advanced forms of cancer treatment to the region.